Investment Stage

Focus Areas

About Investor

Jamil M. Beg is Partner at SV Health Investors on the therapeutics team. He is a life-science investor and company builder focused on translating breakthrough science into transformational medicines, working across biotech company creation, private financings, public offerings, and M&A. Before SV, he was a Partner at 5AM Ventures, investing in biotech companies across therapeutic areas and modalities from company creation to clinical-stage companies. His operating and investment background includes Akouos, Aprea, Kinaset Therapeutics, Nido Biosciences, RallyBio, Sage Therapeutics, Transave Inhalation Therapeutics, and several stealth biotech startups.